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Summary 
Previous studies showed that grasshopper semapho- 
rin I, a transmembrane semaphorin, functions in vivo 
to steer a pair of growth cones, prevent defascicula- 
tion, and inhibit branching; and that chick collapsin, 
a secreted semaphorin, can function in vitro to cause 
growth cone collapse. Semaphorin II, a secreted sema- 
phorin in Drosophila, is transiently expressed by a sin- 
gle large muscle during motoneuron outgrowth and 
synapse formation. To test the in vivo function of 
semaphorin II, we created transgenic Drosophila that 
generate ectopic semaphorin II expression by muscles 
that normally do not express it. The results show that 
semaphorin II can function in vivo as a selective target- 
derived signal that inhibits the formation of specific 
synaptic terminal arbors. 
Introduction 
The formation of specific synaptic connections is gener- 
ated in part by the molecular mechanisms controlling 
growth cone guidance and target recognition (reviewed 
by Goodman and Shatz, 1993; Goodman, 1994). Pathway 
and target recognition is mediated by a range of mecha- 
nisms, including contact-mediated attraction, chemoat- 
traction, contact-mediated repulsion, and chemorepul- 
sion. Members of a variety of gene families have been 
implicated to function in vivo as signals for pathfinding 
and targeting, including, for example, members of the im- 
munoglobulin (Grenningloh et al., 1991; Ramos et al., 
1993; Lin et al., 1994; Chiba et al., 1995) leucine-rich 
repeat (Noseet al., 1992,1994), netrin/UNC-6(Hedgecock 
et al., 1990; lshii et al., 1992; Hamelin et al., 1993; Serafini 
et al., 1994; Kennedyet al., 1994) and semaphorin (Kolod- 
kin et al., 1992, 1993; Luo et al., 1993) gene families. 
The semaphorins are a family of cell surface and se- 
creted proteins that are conserved from insects to hu- 
mans. Semaphorins are - 750 amino acids in length (in- 
cluding signal sequence) and are defined by a conserved 
- 500 amino acid extracellular semaphorin domain con- 
taining 14-16 cysteines, many blocks of conserved resi- 
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dues, and no obvious repeats (Kolodkin et al., 1992,1993; 
Luo et al., 1993). The transmembrane semaphorins have 
an additional - 60 amino acid stretch, a transmembrane 
domain, and a 60-110 amino acid cytoplasmic domain. 
The secreted semaphorins have an additional -20 amino 
acid stretch, a single immunoglobulin domain, and a 70- 
120 amino acid C-terminal region. In addition, two sema- 
phorins are encoded in viral genomes (Kolodkin et al., 
1993). 
Two complementary sets of results suggest that sema- 
phorins can function as signals that guide growth cones. 
First, semaphorin I (Kolodkin et al., 1992) a transmem- 
brane semaphorin in insects, functions in the grasshopper 
limb bud to stall and then steer a pair of growth cones as 
they encounter epithelial cells expressing it. Semaphorin 
I also prevents the axons that encounter it from defascicu- 
lating and inhibits branching. Second, collapsin, a se- 
creted semaphorin in chick, in vitro can cause the collapse 
of growth cones from dorsal root ganglion neurons (Luo 
et al., 1993). 
Semaphorin II is a secreted semaphorin in Drosophila 
that is dynamically expressed during embryonic develop- 
ment by a subset of neurons in the central nervous system 
(CNS) and by a single large thoracic muscle in the periph- 
ery (Kolodkin et al., 1993). Its transient expression by a 
specific muscle during motoneuron outgrowth and syn- 
apse formation suggests that, among its potential roles, 
semaphorin II might function as a secreted target-derived 
signal that regulates the formation of synaptic connec- 
tions. 
The generation of neuromuscular specificity in Drosoph- 
ila provides an ideal system for testing the in vivo function 
of such a putative guidance and targeting molecule be- 
cause much is already known about the cellular environ- 
ment, pathfinding, and targeting events that underlie its 
development (e.g., Sink and Whitington, 1991; Van Vactor 
et al., 1993; Keshishian et al., 1993; Broadie et al., 1993). 
All motoneuron growth cones and axons express fasciclin 
II during axon outgrowth and synapse formation (Van Vac- 
tor et al., 1993) and thus can be visualized using the 1 D4 
monoclonal antibody (MAb) that recognizes fasciclin II (G. 
Helt and C. S. G., unpublished data). Moreover, some 
embryonic motoneurons (e.g., RP3 and RPl) can be pene- 
trated with microelectrodes and filled with dye to reveal 
their growth cones and terminals (Sink and Whitington, 
1991). 
To test the in vivo function of semaphorin II during 
growth cone guidance and target recognition, we created 
transgenic Drosophila that express semaphorin II by mus- 
cles that normally do not express it. The results show that 
semaphorin II can function as an inhibitory signal during 
target recognition. Semaphorin II inhibits two identified 
motoneuron growth cones (RP3 and DCl) from forming 
normal synaptic terminal arborizationson their target mus- 
cles, while two other growth cones (RPl and RP4) appear 
unresponsive to contact with the protein. 
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Results 
Semaphorin II is normally expressed by ventral muscle 
33 in thoracic segment T3 (Hooper, 1986) (Figures 16 and 
2A). On either side in each larval abdominal segment from 
A2 to A7 in Drosophila, there are a total of 30 muscles 
(l-30), including four prominent internal ventral longitudi- 
nal muscles (from ventral to dorsal): 7, 6, 13, and 12 (Fig- 
ures 1A and 28). The ventral muscles in the first abdominal 
segment (Al) are largely identical to those found in A2- 
A7, except for one additional muscle, 31 (Hooper, 1986) 
just internal to muscles 7, 6, and 13 (Al is also missing 
two muscles, 17and 25; Bate, 1993). The pattern of ventral 
muscles in segment T3 displays a number of differences 
from abdominal segments, among them being muscle 33 
just internal to muscles 7, 6, 13, and 12. Larval muscle 
33 stretches across the other thoracic segments to attach 
to the mouth parts (Hooper, 1986; Bate, 1993). All of these 
Figure 1. Motoneuron Projections in Relation 
to Semaphorin II Expression in Wild-Type and 
Toll-semall Transgenic Embryos 
Schematic diagrams of the ventral muscles in 
the T3, Al, and A2-A7 segments of the Dro- 
sophila embryo, focusing on those muscles in- 
nervated by SNb, and the identity, synapses, 
axon trajectories, and cell body locations of 
identified SNb motoneurons. SN, segmental 
nerve; ISN, intersegmental nerve; RPl, RP3, 
RP4, and RP5, identified motoneurons in the 
RP cluster: DCI, identified motoneuron in- 
nervating muscle 31 in segment Al and not a 
member of the RP cluster; numbers refer to 
muscle identities: L, longitudinal connectives; 
AC and PC, anterior and posterior commis- 
sures. 
(A) The embryonic motoneuron branches (with 
details of the SNb) and ventral muscles in hemi- 
segments of abdominal segments A2-A7, 
which have four internal longitudinal ventral 
muscles (7,6,13, and 12) and of segment Al, 
which has an extra internal longitudinal ventral 
muscle (31) are shown schematically. Dia- 
gram in the middle is a view from the internal 
surface (dorsal is up; anterior is to left). Dia- 
gramsat leftandrightarecross-sectionalviews 
(dorsal is up; inner surface is to left, outer sur- 
face to the right). 
(6) Enlarged view of the ventral muscles and 
their innervation as visible from an internal 
view, showing muscle 33 in segment T3, which 
expresses high levels of semaphorin II in wild- 
type embryos. 
(C) Ectopic expression of semaphorin II in Toll- 
semall embryos. Note high levels of semapho- 
rin II expression by muscles 15, 16, 7, 6, and 
31 and low levels by muscles 17, 12, and 33, 
as driven by the Toll-small transgene (in the 
embryo, this is superimposed on the normal 
high level of expression by muscle 33). Dia- 
gram shows resulting pattern of SNb branching 
and innervation in Al and A2 segments as 
viewed from internal surface; note absence of 
normal pattern of innervation of muscles 7, 6, 
and 31. See text for further details. 
internal ventral muscles are innervated by branches of 
segmental nerve b (SNb), including muscle 33 in segment 
T3 (Figure 1A). 
At late stage 16learly stage 17, the synaptic arboriza- 
tions on muscles 7,6,13, and 12 in Al -A7 and on muscle 
31 in Al are all easily visualized with MAb lD4 (anti- 
fasciclin II) (Figures 3A and 3C) and are accessible to 
1 ,l’dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine per- 
chlorate (Dil) backfills in dissected embryos (data not 
shown). Most of the motoneurons that innervate these 
muscles can be readily identified in the CNS, penetrated 
with microelectrodes, and filled with the intracellular dye 
Lucifer yellow (LY) (Figures 4A and 4B). In these ways, 
we can study the innervation of these muscles in wild-type, 
mutant, and transgenic embryos. 
The RP3 growth cone synapses on muscles 7 and 6 in 
the cleft between these two muscles; RPl and RP4 growth 
cones synapse on the proximal edge of muscle 13, and 
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RP5 synapses on muscle 12 (see Figures 1 A and 1 B; Fig- 
ures 4A and 48) (Sink and Whitington, 1991; Van Vactor 
et al., 1993). In the present study, we used Dil backfills 
from the synapse to show that muscle 31 in segment Al 
is innervated at early stage 17 on its dorsal edge by at 
least one motoneuron, called DC1 , which has an ipsilateral 
cell body lateral to the longitudinal connectives (see Fig- 
ure 1A). 
Figure 2. Muscle Expression of Semaphorin II RNA in Wild-Type and 
Toll-semall Transgenic Embryos 
Whole-mount dissections of early stage 16 Drosophila embryos (ante- 
rior to left, dorsal up) showing expression of semall RNA in wild-type 
(A) and Toll-semall transgenic (B) animals as revealed by digoxygenin 
whole-mount in situ hybridization. (A) The semall RNA is transiently 
expressed at high levels in muscle 33 in segment T3 in wild-type em- 
bryos. (B) In Toll-semall embryos, semall RNA is expressed at high 
levels in muscles 15,16,7. and G(and at lower levels in other muscles; 
see Figures 1 and 5 and text for details). Scale bar, 30 urn. 
Figure 3. Ectopic Semaphorin II Expression Alters Muscle Innervation 
Photomicrographs of two abdominal segments in late stage 16 filleted wild-type (A and C) and Toll-semall (B and D) embryos as stained with 
MAb 1 D4 (anti-fasciclin II) and horseradish peroxidase immunohistochemistry. 
(A and 6) Pairs of abdominal segments A2-A7. The focus is on the cleft between muscles 7 and 6 (arrow), where in wild type (A) the RP3 growth 
cone has transformed into a synaptic terminal arbor. Note the absence of the normal terminal arbor in the Toll-semall transgenic embryo (B). 
(C and D) Pairs of abdominal segments Al and A2. The focus is on the dorsal edge of muscle 31 in segment Al (left arrow in left segment), where 
in wild type (C) the DC1 growth cone has transformed into a synaptic terminal arbor, and on the cleft between muscles 7 and 6 (right arrow in 
right segment), where in wild type(C) the RP3 growth cone has transformed into a synaptic terminal arbor. Note the absence of the normal terminal 
arbor on muscle 31 in segment Al and on muscles 7 and 6 in segment A2 in the Toll-semall transgenic embryo (D). Numbers refer to muscle 
identities. Scale bar, 10 pm. 
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In contrast with the relative ease of studying the internal 
ventral muscles in segments Al-A7, the innervation of 
muscle 33 in segment T3 is very difficult to study because 
it is innervated on its external face on the opposite side 
from the surface exposed in dissected embryos. Thus, we 
do not know the identity of which motoneuron(s) innervates 
it in wild-type, in mutant, or in transgenic embryos. 
During early to mid-stage 16, SNb growth cones make 
extensive filopodial contact with both their target muscles 
and adjacent muscles. By late stage 16, these growth 
cones retract their filopodia on adjacent muscles and form 
functional synapses on their appropriate target muscles, 
a process that is complete by early stage 17. Thus, our 
analysis of growth cone behavior is focused on late stage 
1 G/early stage 17 when in wild-type embryos the normal 
pattern of synaptic innervation is already present. 
We first examined embryos homozygous for loss-of- 
function mutations in the semaphorin II gene, semall (Ko- 
lodkin et al., 1993). Semaphorin II is normally expressed by 
muscle 33 in segment T3. Using 1 D4 staining, no dramatic 
loss-of-function phenotype is seen in the pattern of SNb 
branching around muscle 33 in segment T3 in semall mu- 
tant embryos. This observation is reminiscent of previous 
studies in this same system that showed that the ectopic 
expression of connectin generates a much stronger and 
more penetrant phenotype (the gain of function) than does 
simply removing the protein (the loss of function) (Nose 
et al., 1994). With the connectin experiments (Nose et 
al., 1992, 1994) as our paradigm, we next examined the 
Figure 4. Ectopic Semaphorin II Expression 
Alters RP3 Development 
Photomicrographs of late stage 16 filleted em- 
bryos in which the cell bodies of the RP3 (and 
RPl in [A] and (B]) motoneurons have been 
penetrated with microelectrodes and filled with 
the dye LY, followed by horseradish peroxi- 
dase immunocytochemistry using an anti-LY 
antibody. The left-right pairs shown in (A) and 
(B), (C)and (D), and (E) and (F) are two different 
focal planes of the same preparations. The left 
focal plane in each pair is on the cleft between 
muscles 7 and 6, where in wild-type embryos 
the RP3 growth cone would have transformed 
into a synaptic terminal arbor. The right focal 
plane in each pair is external to muscles 7 and 
6 and just internal to muscles 14 and 30. This 
is the region where the FtP3 growth cone is 
often located in Toll-semell tranegenic em- 
bryos at this stage. 
(A and B) An example of wild-type morphology 
of the RP3 (A) and RPl (6) terminal arbors in 
a Toll-semall transgenic embryo; wild-type 
morphology was observed in about 30% of 
RP3 motoneurons filled with dye in these 
transgenic embryos. Note that this is an exam- 
ple from a double fill of both neurons. 
(C and D; E and F) Two examples of abnormal 
RP3 growth cones in Toll-semall transgenic 
embryos. Instead of forming a normal synaptic 
terminal arborization in the cleft between mus- 
cles 7 and 6 (C and E), RP3 instead is still a 
growth cone in the region around muscle 14. 
See text for further details. Scale bar, 10 pm. 
gain-of-function phenotype by ectopically expressing sem- 
aphorin II by other ventral muscles whose innervation is 
well known. 
We used P element-mediated transformation to gener- 
ate ectopic expression of semaphorin II by a different sub- 
set of ventral embryonic muscles during motoneuron path- 
finding and targeting. We used a heterologous enhancer 
(from the To// gene) to ectopically express semaphorin II 
in all segments by some of the ventral muscles that nor- 
mally do not express it, but that are adjacent to the nor- 
mally semaphorin II-expressing muscle 33 in segment T3 
(see Figures 1C and 28). 
Toll is expressed on a subset of embryonic muscles 
(Nose et al., 1992). A 6.5 kb fragment in the 5’ flanking 
region of the Toll gene was previously shown to function 
as an enhancer element that can drive expression of a 
lad reporter gene in a subset of muscles (Wharton and 
Crews, 1993). At stage 16, /acZ is driven at high levels in 
muscles 26,14-16,7, and 6 and at lower levels in muscles 
30, 17, 13, and some lateral muscles (Nose et al., 1992); 
we also observe /acZ at a high level in muscle 31 in Al 
and at a lower level in muscle 33 in T3. 
This 6.5 kb fragment of the Toll gene was previously 
used to ectopically express connectin (Nose et al., 1994) 
and here it was used ectopically to express semaphorin 
II by these ventral muscles (see Figures 1C and 28). The 
construct contains the 6.5 kb Toll enhancer, the hsp70 
promoter, a semall cDNA with the entire open reading 
frame, and the SV40 polyadenylation site, all inserted into 
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Table 1. Defects in Innervation of Ventral Muscles by SNb Motoneurons in Different Genotypes with P Elements Driving Ectopic Semaphorin 
II Expression 
P Element 
Late Stage 16 Mid-Stage 17 
Genotype” 
Wild type 
6071607 
6851685 
COPY 
Number 
0 
2 
2 
Muscles 6/7 
(AZ-A7) % 
3 (59)b 
64 (123) 
68 (104) 
Muscle 31 Muscle 13 Muscles 6/7 Muscle 31 Muscle 13 
(Al) Q/o (A2-A7) % (AZ-A7) % (Al) O/o (A2-A7) % 
0 (9) 0 (70) 0 (40) 0 (8) 0 (48) 
50 (8) 0 (44) 27 (132) 80 (15) 0 (95) 
81 (13) 0 (104) 29 (41) 60 (5) N (40) 
78178 2 53 (184) 57 (21) 0 (141) ND ND 
6851685; 78178 4 74 (59) 60 (10) 0 (59) ND ND 
B For details on generation of specific P element genotypes, see Experimental Procedures. 
D Percent is of muscle innervation absent. Numbers shown in parentheses are number of segments examined. 
ND, not determined. 
ND 
ND 
a P element vector. Thirteen independent Toll-semall 
transformant lines were isolated, three of which are ana- 
lyzed here (Table 1). 
As expected, semall mRNA is ectopically expressed by 
the normally Toll-positive ventral muscle fibers in Toll- 
semall embryos (see Figure 28). The ectopic muscle ex- 
pression is first detected at stages 1 l-l 2, peaks at stages 
14-15, and declines during stage 16. It is strongest in 
muscles 26, 14-16, 7, and 6. By late stage 16, ectopic 
semall mRNA expression can no longer be detected. The 
6.5 kb Toll enhancer drives expression of a reporter IacZ 
gene in some other tissues known to express Toll, includ- 
ing the dorsal vessel (Wharton and Crews, 1993). Ectopic 
semall mRNA expression persists into stage 17 in the dor- 
sal vessel, thus allowing for the unambiguous identifica- 
tion of embryos carrying the transgene at this stage. 
No gross defects are seen in the CNS or in the periphery 
in the Toll-semall embryos. The development of the mus- 
cles that ectopically express semaphorin II appears nor- 
mal in Toll-semall embryos, as indicated both by their 
morphology (as visualized with Nomarski optics) and their 
expression of various other surface markers (fasciclin Ill 
and fasciclin II) during stages 15-l 7. The timing and mor- 
phology of the differentiation of the muscle pioneers, mus- 
cle insertions, and myoblast fusions to the pioneers are 
normal in the semaphorin h-expressing muscles in these 
embryos. These observations suggest that the ectopic ex- 
pression of semaphorin II does not alter the differentiation 
of ventral muscles per se. 
The innervation of muscles 7 and 6 by the RP3 motoneu- 
ron is dramatically altered in Toll-semall embryos (see 
Figure3B; Table 1); innervation is used here as an anatom- 
ical description of the normal terminal synaptic arboriza- 
tion in the cleft between muscles 7 and 6. In Toll-semall 
embryos, muscles 7 and 6 appear uninnervated in 53%- 
66% of segments at late stage 16 (depending upon which 
line is examined; see Table 1). A prominent feature of the 
abnormal SNb projection at this stage is the large growth 
cone processes emanating from the SNb axons just be- 
yond muscle 14 and near to or in contact with muscle 30. 
During mid-stage 17, several hours after ectopic sema- 
phorin II expression has disappeared, muscles 7 and 6 
remain uninnervated in 270/o-29% of segments. In con- 
trast, in wild-type embryos of the same genetic back- 
ground but lacking the Toll-semall transgene, muscles 7 
and 6 are innervated in >97% of segments at late stage 
16 and 100% of segments at mid-stage 17. 
Intracellular dye fills of the RP3 motoneuron (Sink and 
Whitington, 1991) in Toll-semall embryos (line 6651665) 
at late stage lG/early stage 17 confirm this result: 11 of 
16 RP3 axons (69%) were abnormal. Instead of forming 
the normal synaptic terminal arborization in the cleft be- 
tween muscles 7 and 6 (Figures 4C and 4E), these RP3 
growth cones are instead just external to muscles 7 and 
6, near muscle 14 and often near muscle 30 as well (Fig- 
ures 4A and 4B, Figures 4C and 4D, and Figures 4E and 
4F show different focal planes of the same preparations). 
These results are summarized in Figure 58. 
Although the muscles appear normal in Toll-semall em- As a control, the innervation of muscle 13 by both RPl 
bryos, we observe abnormalities in the development of and RP4 appears unperturbed in 100% of segments in 
certain branches of the SNb motor nerve that normally Toll-semall embryos (Table 1). Muscle 13 is likely to ex- 
innervate muscles 7 and 6 in all abdominal segments and press low levels of semaphorin II in Toll-semall embryos. 
muscle 31 in Al. We observe the same phenotypes in all In addition, to reach muscle 13, the motoneurons that in- 
three Toll-semall lines examined (Table 1). The effects of nervate it (RPl and RP4) normally extend between mus- 
ectopic semaphorin II expression are specific to SNb and cles that express very high levels of semaphorin II in Toll- 
SNd motoneurons. The other three motor nerves (the inter- semall embryos (e.g., in the region between muscles 15, 
segmental nerve, SNa, and SNc) retain their normal mor- 26,14,7, and 6) (see Figures 1 and 5). This axon trajectory 
phology and branching in Toll-semall embryos. The SNd appears normal in Toll-semall embryos. Moreover, intra- 
motoneurons, which normally innervate muscles 15-l 7 cellular dye fills of RPl in Toll-semallembryos at late stage 
(which ectopically express semaphorin II in Toll-semall 1 G/early stage 17 reveal that 7 of 7 RPl axons follow their 
embryos), display less severe abnormalities at similar fre- normal trajectory to innervate the inner surface of muscle 
quencies to the SNb in these embryos. 13 (Figure 58). 
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Figure 5. Behavior of RP3 and RPI Growth Cones in Response to 
Ectopic Semaphorin II Expression 
(A) Schematic diagrams showing cross-sectional views of wild-type 
pattern of RP3 and RPI motoneuron axon trajectories and synaptic 
connections. In late stage 16 wild-type embryos, RP3 and RPI growth 
cones have reached their targets and transformed into synaptic termi- 
nal arbors. The numbers are muscle identities. External is to the right. 
The intersegmental nerve(ISN) innervatesdorsal muscles, while SNb, 
which contains the RP3 and RPI axons, innervates ventral muscles. 
The RP3 motoneuron innervates muscles 7 and 6; RPI innervates 
muscle 13. 
(9) In To//-sernall embryos, semaphorin II is ectopically expressed at 
high levels by muscles 15, 16, 28, 14, 7, and 6 and at much lower 
levels by muscles 17 and 13. The RP3 motoneuron shows dramatic 
abnormalities, typically entering the ventral muscle field at the normal 
location and extending to the region near muscle 14, but (so long as 
semaphorin II is expressed) failing to innervate muscles 7 and 6. RPI 
appears wild type in these embryos. 
We also examined the innervation of muscle 31 in seg- 
ment Al in Toll-semall embryos. Muscle 31 expresses 
high levels of semaphorin II in these embryos. The DC1 
motoneuron, which innervates muscle 31, normally fol- 
lows the same trajectory as the RPI motoneuron innervat- 
ing muscle 13 (see Figure 1A). Instead of innervating the 
inner surface of muscle 13, DC1 extends inward to inner- 
vate the dorsal surface of muscle 31 (see Figures 1 and 
3C). In Toll-semallembryos, DC1 is abnormal. In wild-type 
embryos, muscle 31 is innervated in 100% of Al segments 
at late stage 16 (Table 1). However, in Toll-semall em- 
bryos, DC1 does not innervate muscle 31 in 60%-60% 
of segments at mid-stage 17 (see Figure 3D), depending 
upon the line examined (Table 1; because there is only one 
Al segment per embryo, the total number of Al segments 
examined is much lower than A2-A7, and thus the differ- 
ences between different lines and stages are not signi- 
ficant). 
The phenotypes observed with MAb 1 D4 staining (see 
Figure 3) do not qualitatively change in embryos from three 
different transgenic lines carrying independent insertions 
that drive different levels of expression and, as a result, 
different levels of phenotypic penetrance (Table 1). The 
phenotypes also do not qualitatively change in embryos 
carrying four copies of the transgene as compared with 
two copies (Table 1). The penetrance of the muscle 6/7 
phenotype increases slightly (from 53%-68% in the two 
parental two-copy lines to 74% in the combined four-copy 
line), but no new phenotypes are observed in embryos 
carrying an increased copy number. Most important, in all 
lines and all dosages, the RP3 growth cone enters the 
ventral muscle region but stalls near muscle 14 and fails 
to form its synaptic terminal arborization on its normal 
target muscles 7 and 6. All that changes is the penetrance 
of this phenotype. 
Discussion 
The present study shows that semaphorin II in Drosophila 
can function in vivo as a target-derived signal that inhibits 
the formation of synaptic terminal arbors. In contrast with 
connectin (Nose et al., 1994) netrin-1 (Colamarino and 
Tessier-Lavigne, 1995 [this issue of Ce//)), and semaphorin 
Ill (Messersmith et al., 1995) which can function as repel- 
lents for growth cone pathfinding, semaphorin II appears 
to be able to function in vivo in a qualitatively different 
fashion as an inhibitor of synapse formation during target 
recognition. 
Semaphorin II is transiently expressed by a single large 
ventral muscle in segment T3 during motoneuron out- 
growth. We tested the in vivo function of semaphorin II 
by creating transgenic Drosophila that generate ectopic 
semaphorin II expression by other ventral muscles in tho- 
racic and abdominal segments that normally do not ex- 
press it. The results lead to three major conclusions. 
First, when semaphorin II is ectopically expressed by 
many ventral muscles along the SNb pathway, the RPl 
and RP4 growth conesare unperturbed in their pathfinding 
toward their target, muscle 13 (which does express sema- 
phorin II, but at considerably lower levels than by the tar- 
gets of RP3, muscles 7 and 6). These growth cones path- 
find right between muscles 15, 28, 14, 7, and 6, which 
express high levelsof semaphorin II. Thus, the pathfinding 
of these growth cones (and perhaps their targeting as well) 
appears unresponsive to semaphorin II. Moreover, there 
is nothing intrinsically nonpermissive about the SNb path- 
way in the Toll-semall embryos. 
Second, when semaphorin II is ectopically expressed 
at high levels by muscles 7 and 6 (the normal targets for 
RP3), the RP3 growth cone is inhibited from forming a 
normal synaptic terminal arborization with its two target 
muscles. Similarly, when semaphorin II is ectopically ex- 
pressed by muscle 31 in segment Al, DC1 is also inhibited 
from forming its normal synaptic arborization. These re- 
sults indicate that semaphorin II can function as a target- 
derived inhibitor. 
Third, the RP3 growth cone, while inhibited from forming 
its synaptic arborization, is not prevented from extending 
into the region of muscles expressing high levels of sema- 
phorin II. It extends within several microns of muscles 15, 
28, 14, 7, and 6 and is often located in close proximity to 
muscle 14. All of these muscle8 express high levels of 
semaphorin II. This result indicates that for certain neu- 
rons, semaphorin II can inhibit the growth cone from form- 
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ing a synaptic arborization, without repelling growth into 
the region where the protein is expressed. 
Taken together, these results suggest that the RP3 and 
DC1 growth cones express a semaphorin II receptor on 
their surface that confers an inhibitory response to this 
signal. The RPl and RP4 growth cones either do not ex- 
press this receptor or, alternatively, express the receptor 
but are nevertheless unresponsive to semaphorin II. As 
discussed below, this putative semaphorin II receptor on 
the RP3 and DC1 growth cones can prevent growth cone 
branching and exploration and inhibit them from forming 
synaptic arborizations, but it does not appear to deter 
growth cone pathfinding. 
The Guidance Functions of Semaphorin II 
versus Connectin 
Insight thus far into how semaphorin II and connection 
function during pathfinding and targeting has come largely 
from gain-of-function experiments using ectopic expres- 
sion. The RPl growth cone clearly behaves quite differ- 
ently when the two guidance signals are ectopically ex- 
pressed by the same muscles. In the semaphorin II 
experiments, FiPl appears unresponsive, extending along 
its normal trajectory and innervating muscle 13 in a normal 
fashion. In contrast, in the connectin experiments (Nose 
et al., 1994), RPl changes its trajectory and takes a detour 
to reach muscle 13, thus avoiding the ectopic connectin- 
expressing muscles. These results suggest that the RPl 
growth cone expresses a functional receptor for connectin 
that confers a repulsive role during pathfinding, but not 
for semaphorin II. 
In one respect, the RP3growth cone behaves similarly in 
both experiments, being inhibited from forming a synaptic 
arborization on its normal targets (muscles 7 and 6) when 
they ectopically express either molecule. These results 
indicate that RP3 expresses receptors for both signals. 
However, there is also one interesting difference in the 
RP3 growth cone behavior in the two experiments. When 
connectin is ectopically expressed, RP3 does not enter 
the ventral muscle field in the normal location, but rather 
either stalls at this location or detours around the con- 
nectin-expressing muscles. Thus, connectin appears to 
repel RP3 pathfinding. In contrast, when semaphorin II 
is ectopically expressed at the same time by the same 
muscles, RP3 behaves quite differently. RP3 enters the 
ventral muscle field in the normal location. RP3 only stalls 
when it nears its semaphorin h-expressing target muscles. 
It is possible that the qualitative differences in RP3 be- 
havior simply reflects quantitative differences in the levels 
of expression of the two guidance signals. Arguing in favor 
of real qualitative differences in responsiveness, however, 
are the observations on penetrance and dosage. In each 
experiment, RP3 was examined in multiple independent 
transgenic lines with independent insertions and with dif- 
ferent copy number of insertions (e.g., homozygous ver- 
sus heterozygous) driving different levels of expression. 
Nevertheless, the only differences observed were in the 
penetrance of the RP3 phenotype, not in the quality of the 
phenotype. Moreover, these different lines drive expres- 
sion of both connectin protein and semall RNA that ap- 
pears to be within the normal range of biological expres- 
sion, suggesting that these qualitative differences are 
biologically significant. These results suggest that con- 
nectin functions as a repellent for RP3 pathfinding and 
targeting, while semaphorin II functions in a qualitatively 
different fashion to inhibit the formation of RP3 synaptic 
arborizations on muscles 7 and 6. 
This qualitative difference in RP3 behavior when ex- 
posed to connectin versus semaphorin II could be ex- 
plained by differences in either the timing or the quality 
of receptor-mediated response. In the first model, RP3 is 
equally inhibited by both semaphorin II and connectin, but 
simply expresses functional semaphorin II-repulsive re- 
ceptors at a later time during its journey toward its target 
muscles. In the second model, the quality of the response 
to the two signals is different, connectin equally repelling 
the RP3 growth cone during both pathfinding and tar- 
geting, with semaphorin II inhibiting RP3 during targeting 
while not repelling its axon growth. 
These results suggest that neuromuscular specificity is 
controlled by a combination of attraction versus inhibition, 
repulsion, or both, that these signals can either be se- 
creted or cell surface, that different motoneuron growth 
cones express different combinations of receptors, and 
that these receptor systems can function in either pathfind- 
ing or targeting or in both events. In such a model, different 
types of inhibitory and repulsive molecules play different 
roles in establishing the final pattern of axon projections 
and synaptic connections. In this way, each motoneuron 
has its own particular response profile in terms of both its 
pathfinding and targeting preferences. 
Inhibitory and Repulsive Functions of Semaphorins 
These observations on semaphorin II function in the Dro- 
sophila embryo are similar in certain respects to previous 
results on semaphorin I function in the grasshopper limb 
bud (Kolodkin et al., 1992). Semaphorin I functions tostall 
and then steer the pair of Ti 1 growth cones as they encoun- 
ter a stripe of epithelial cells expressing it. The expression 
of semaphorin I on epithelial cells prevents the Til axons 
that encounter it from defasciculating and inhibits branch- 
ing. However, although having a potent affect on their 
steering, fasciculation, and branching, the Til growth 
cones are still able to grow on the semaphorin I-express- 
ing cells (see discussion in Kolodkin et al., 1993). Similarly, 
as shown here in Drosophila, RP3 enters into the region 
of muscles expressing semaphorin II, but it fails to form 
synaptic arborizations on its targets. 
An interesting comparison can also be made between 
the in vivo results reported here and previously (Kolodkin 
et al., 1992) for semaphorin I and semaphorin II function 
in insects and the in vitro results reported previously for 
retinal ganglion growth cones in the rat (Roskies and 
O’Leary, 1994). In an in vitro stripe assay, temporal retinal 
axons can extend across alternating membranes from the 
topographically correct rostra1 superior colliculus and the 
incorrect caudal superior colliculus of embryonic rats. 
They are not repelled by the incorrect membranes, but 
rather preferentially branch on the correct membranes and 
do not branch on the wrong ones. This branching prefer- 
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ence is due to a molecule in the caudal superior colliculus 
that inhibits branching of temporal retinal axons. These re- 
sults lead to the suggestion that in certain contexts, some 
guidance molecules may inhibit axon branching without re- 
pelling axon growth (Roskies and O’Leary, 1994). 
For the Drosophila RP3growth cone in vivo, semaphorin 
II does not appear to repel axon growth, but rather does 
behave as a potent inhibitor of synapse formation. For 
mammalian sensory axons in vitro, semaphorin Ill can 
function as a selective chemorepellent (Messersmith et 
al., 1995). Whether these differences in inhibition versus 
repulsion are biologically significant or simply reflect the 
different types of in vivo and in vitro assays used remains to 
be determined. In the developing organism, semaphorins 
appear capable of inhibiting branching (semaphorin I in 
grasshopper), influencing steering decisions (semaphorin 
I in grasshopper and semaphorin Ill in mammals), pre- 
venting axons from entering certain target regions (sema- 
phorin II in Drosophilaand perhapssemaphorin Ill in mam- 
mals), or inhibiting the formation of synaptic terminal 
arborizations (semaphorin II in Drosophila). It is possible 
that the same molecule may play different roles in different 
contexts within the same developing organism. In this re- 
gard, it will be important in the future to identify the recep- 
tor(s) for semaphorins and begin to elucidate their signal 
transduction mechanisms in these different contexts. 
The Loss of Function versus the Gain of Function 
One finding in the present study is that the ectopic expres- 
sion of semaphorin II generates a much stronger and more 
penetrant phenotype (the gain of function) than does sim- 
ply removing the protein (the loss of function). A similar 
conclusion was reached in the previous analysis of con- 
nectin function (Nose et al., 1994) and in a recent analysis 
of fasciclin Ill function in this same system (Chiba et al., 
1995). This striking trend, in which the ectopic expression 
of three different targeting molecules yields stronger phe- 
notypes than the loss of function, must reflect some inher- 
ent property in the way targeting systems are built. For 
example, the identity of a target may be specified not by 
a single molecule, but rather by a combination of different 
molecules, each of which is interpreted as either attractive 
or repulsive by particular growth cones depending upon 
the combination of receptors they express. If this is cor- 
rect, then the introduction of one of these components in 
a novel location might have a more disruptive effect on the 
final outcome than would removal of any one component. 
Based on our analysis of connectin function (Nose et 
al., 1994), we previously suggested that some guidance 
molecules may be in part refractory to loss-of-function ge- 
netic analysis in which gene functions are removed one 
at a time. Rather, molecular genetic methods that rely on 
the ectopic expression of these molecules may be required 
to reveal their function more clearly. Previous systematic 
genetic screens for mutations with highly penetrant pheno- 
types that perturb specific aspectsof neuromuscular spec- 
ificity in the Drosophila embryo did not recover mutations 
in either the semall, connectin, or faslll genes (Van Vactor 
et al., 1993; Sink and Goodman, 1994, Sot. Neurosci., 
abstract). And yet all three of these genes appear to en- 
code important targeting signals in this system (Nose et 
al., 1994; Chiba et al., 1995; this paper). 
Experimental Procedures 
Expression Construct and Germline Transform&Ion 
pCaSpeR2/17(Nose et al., 1994), a transformation vectorthat contains 
the white+ (w+) gene, hsp70 promoter, and SV40 polyadenylation site, 
was cut between the promoter and polyadenylation site. A 2.6 kb Asp- 
718-Xbal fragment of Drosophila semall containing the entire open 
reading frame and 400 bp of 5’and 230 bp of 3’untranslated sequence 
was inserted into the cut vector. A 8.5 kb Notl fragment of the Toll 
enhancer region (Wharton and Crews, 1993) was then inserted 5’ to 
the hsp70 promoter in the pCaSpeR-semall construct to form the ex- 
pression constructpCaSpeR-Toll-semall. Each newly formed junction 
was sequenced with pCa.SpeR-specific primers. 
The pCaSpeR-Toll-semall construct was introduced into w”‘~ em- 
bryos by P element-mediated transformation (Spradling and Rubin, 
1982) with the helper plasmid pUChspAP-3. We established 13 inde- 
pendent transformants lines, including 457, 483, and 685, each with 
an insert on chromosome 2, and 78 and 687, each with an insert 
on chromosome 3. Most have near wild-type levels of semall mRNA 
expression in the To// muscle pattern (highest in muscles 14-16; less 
in 17, 7, and 6; and lower still in 5, 22-24, and 31) as compared with 
the normal expression in muscle 33 in segment T3. 
Genetics 
Loss-of-function analysis was done using homozygous line 3021 reel 4, 
a recombined derivative of PI .O (Kolodkin et al., 1993) that has a rosy 
P element inserted in codon 33 of the semall open reading frame. 
This recombinant line is homozygously semiviable and fertile (M. Win- 
berg and A. L. K., unpublished data), although the adults behave ab- 
normally in visual orientation tests and hold their wings in an abnormal 
posture (Kolodkin et al., 1993). Transgenic lines 685;78, 457;78, and 
483;78each havefourpCaSpeR-Toll-semallinserts. Theywere estab- 
lished by standard genetic crosses. 
lmmunocytochemlstry 
Embryos were dechorionated, fixed, and devitellinized as described in 
Pate1 et al. (1987). Embryos were stained with the following antibodies 
using standard protocols: MAd lD4 (anti-fasciclin II; G. l-felt and 
C. S. G., unpublished data; see Van Vactor et al., 1993), MAb 22ClO 
(Fujita et al., 1982), and anti-p-galactosidase (gift from Ft. Holmgren). 
Embryos were dissected as described elsewhere (Van Vactor et al., 
1993; Kolodkin et al., 1993). 
Staging of embryos was according to Campos-Drtega and 
Hartenstein (1985) and Van Vactor et al. (1993), with particular atten- 
tion to head involution, CNS condensation, gut morphology, and ap- 
pearance of MAb 1 D4 staining of the lateral longitudinal axon tracts. 
Muscle identity and nomenclature are from Crossley (1978), Hooper 
(1988), and Bate (1993). In situ hybridization was performed as de- 
scribed by Kolodkin et al. (1993). 
Intracellular Dye Fills 
Individual RP motoneurons (RPl and RP3) were visualized with No- 
marski optics in unfixed, dissected late stage 18 embryos, identified 
according to their cell body positions between the axon commissures, 
penetrated with microelectrodes, iontophoretically injected with LY as 
described previously (Sink and Whitington, 1991), and processed us- 
ing anti-LY antibody (Molecular Probes) (Taghert et al., 1982). 
Motoneuron DC1 was identified by iontophoretic application of Dil 
(0.4% in ethanol) to the axon of the lateral surface of muscle 31 in 
segment Al. After 15 min, the embryo was fixed for 15 min in 4% 
formalin-citrate phosphate buffer, rinsed extensively with PBS for 30 
min, and then photo-oxidized with DAB (1 mglml) under a rhodamine 
filter set until brown reaction product wasseen in the backfilled neuron. 
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